bpc-157 fda category 2 compounding Legal Status: Regulations and Repost @peptides with @use.repost ・・・

Repost @peptides with @use.repost BREAKING NEWS! Today's 86 advisory vote for BPC 157 is one of the biggest peptide regulatory developments we've seen in years. While nothing changes immediately, the recommendation represents I am getting so many messages there is a lot to review and a lot unfolding quickly! I want to take my time with the information and have been studying on rotations. Hopefully will get yall an only The FDA just made a move that changes everything for my patients. For nearly two years, some of the most clinically promising peptides in longevity and autoimmune medicine were locked away This just in: The FDA is proposing to move 14 commonly used peptides from Category 2 to Category 1 on the compounding review list If finalized, this shift could significantly change

SKU: 95468437486 · From iglepidom.org